| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3847777 | American Journal of Kidney Diseases | 2014 | 10 Pages |
Abstract
The DIPAK 1 Study will show whether subcutaneous administration of lanreotide every 4Â weeks attenuates disease progression in patients with ADPKD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Esther MD, PhD, Joost P.H. MD, PhD, Hedwig MD, Niek F. MD, Johan W. MD, PhD, Tom J. MD, Peter MSc, Dorien J.M. PhD, Mahdi MD, Darius MD, Edwin M. MD, Vicente E. MD, PhD, Folkert W. MD, PhD, Jack F.M. MD, PhD, Robert MD, PhD, Ron T. MD, PhD,